SAN FRANCISCO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for cancer, today announced its participation in several leading healthcare ...
MIAMI, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term ...
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter: Alumis: Top-line ...
A webcast replay of the discussion will be available from the Investors section of the company’s website at www.iobiotech.com for 30 days. A webcast replay of the discussion will be available from the ...
WINNIPEG, Manitoba, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (KNE:CA) (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that the Company will be showcasing its ...
John Swift, a partner and the global science and technology practice leader, has more than 30 years of experience in high performance building systems engineering design. He has delivered solutions ...
Edesa Biotech (EDSA) has released an update. Edesa Biotech, a clinical-stage biopharmaceutical company, is set to participate in multiple international conferences, highlighting its focus on ...
Date: Friday, March 7, 2025 Time: 8:30 a.m. ETDial In – North American Toll-Free: (888) 510-2154Dial In – International: (437) 900-0527RapidConnect: to join the conference call without operator ...
TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...
SAN DIEGO (AP) – The biggest annual biotech conference in the world opened Monday with a panel on one of the industry’s most contentious issues: genetically altered food. Industry supporters launched ...
The biotech industry’s largest annual conclave comes to Boston next week, and it’s a stressful time for those in the business of developing new drugs and medical treatments. Companies are declaring ...
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PT/4:30 p.m. ET on Thursday, February 27, 2025, following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback